Anavex Life Sciences Corp - Company Profile
Powered by 
All the data and insights you need on Anavex Life Sciences Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Anavex Life Sciences Corp Strategy Report
- Understand Anavex Life Sciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Anavex Life Sciences Corp Catalyst Calendar
Proactively evaluate Anavex Life Sciences Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Anavex Life Sciences Corp Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Sep 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Jun 2020 | Phase II Trial Results | Anavex Life Sciences Corp; International Rett Syndrome Foundation; Leon Research SL; Michael J Fox Foundation for Parkinson's Research | AVXL | blarcamesine hydrochloride | Central Nervous System | Cognitive Impairment; Dementia; Parkinson's Disease; Sleep Disorders | Company Press Release |
| 01 Jun 2020 | Phase I Trial Initiation | Anavex Life Sciences Corp; CMAX Clinical Research Pty Ltd | AVXL | ANAVEX-371 | Central Nervous System | Alzheimer's Disease; Parkinson's Disease; Pick Disease | Clinical Trial Registry |
| 01 Mar 2020 | Phase II/III Trial Initiation | Anavex Life Sciences Corp | AVXL | blarcamesine hydrochloride | Central Nervous System | Rett Syndrome | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer